Evaluation of refractory epilepsy treated with vagus nerve stimulation for up to 5 years

Neurology

Volumn 52, Issue 6, 1999, Pages 1265-1267

  Ben Menachem, Elinor ^a   Hellström, Karina ^a   Waldton, Christer ^b   Augustinsson, Lars Erik ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Dicamed Inc   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENCE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DISEASE CONTROL; EVALUATION; FOCAL EPILEPSY; GRAND MAL SEIZURE; HOARSENESS; HUMAN; LENNOX GASTAUT SYNDROME; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REMISSION; SAFETY; TREATMENT INDICATION; TREATMENT OUTCOME; VAGUS NERVE STIMULATION;

EID: 0032920477     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.6.1265     Document Type: Article

References (3)

1. Ben-Menachem E, Mañon-Espaillat R, Ristanovic R, et al. Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. Epilepsia 1994;35:616-626.
2. Handforth A, DeGiorgio CM, Schachter S, et al. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology 1998;5:48-55.
3. Labiner DM, Ahern GL. Meta-analysis of vagus nerve stimulation in treating medically refractory epilepsy. Epilepsia 1997; 38(suppl 8):108.